title: [Proposal for a therapeutic protocol in Crosti lymphoma].
abstract: Three patients with Crosti's lymphoma were treated with radiotherapy using electron accelerators. The energy radiations ranged from 5 to 9 Mev. with large fields. The total dose was 40 Gy, delivered in 2 Gy fractions daily. The treatment lasted four weeks. No side effects were reported and no recurrence was remarked after 24 months.
authors.forename: A M
authors.initials: AM
authors.lastname: Manganoni
authors.forename: B
authors.initials: B
authors.lastname: Morrica
authors.forename: G
authors.initials: G
authors.lastname: Pasolini
authors.forename: P G
authors.initials: PG
authors.lastname: Calzavara
authors.forename: D
authors.initials: D
authors.lastname: Braga
authors.forename: F
authors.initials: F
authors.lastname: Facchetti
authors.forename: R
authors.initials: R
authors.lastname: Gavazzoni
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D010315:Particle Accelerators; D011241:Prednisone / Q000008:administration & dosage; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Proposta di protocollo terapeutico nel linfoma di Crosti.